Regenerative Medicine Market in Japan Research Report covers the present scenario and the growth prospects of the Regenerative Medicine Industry in Japan for 2016-2020. Regenerative Medicine Market in Japan, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Regenerative Medicine Industry in Japan globally.
For further information on this report, please visit- http://www.marketreportsworld.com/10280146
The Regenerative Medicine Market in Japan report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Regenerative Medicine Market in Japan:
- JCR Pharmaceuticals
- Japan Tissue Engineering
- Caladrius Biosciences
Other Prominent Vendors of Regenerative Medicine Market in Japan Are:
- FUJISOFT Tissue Engineering
- MEDI NET
“The vendors in the market are pursuing inorganic growth strategies to expand their presence and expertise. This trend is likely to have a positive impact shortly. In March 2015, Fujifilm and CDI, the leading developers and manufacturers of functioning human cells in industrial quantities, entered into a definitive agreement under which Fujifilm will acquire CDI. In February 2016, Astellas Pharma acquired Ocata Therapeutics, which is a developer of regenerative medicines for eye diseases. In November 2015, ReproCELL completed the acquisition of the Biopta. The acquisition enables the ReproCELL to expand its drug discovery services.”
Ask Sample PDF of Regenerative Medicine Market in Japan Report @ http://www.marketreportsworld.com/enquiry/request-sample/10280146
According to the Regenerative Medicine Market in Japan report, recent product approvals is a key driver which will fuel the market growth. The market has been witnessing new product approvals, which are expected to drive the growth. The new product approvals have the potential to generate substantial revenue in the market. For instance, in September 2015, Mesoblast’s partner JCR Pharmaceuticals received approval of its product TEMCELL for the treatment of pediatric acute GVHD in Japan. This was the first product to be approved under the Japanese regenerative medicine law that enables cell therapy treatment to go directly from the first phase to commercialization. In the same month, Terumo Corporation received conditional approval for manufacturing and commercialization of its product HeartSheet autologous skeletal myoblast sheets.
Report also presents Geographical Segmentation analysis of Regenerative Medicine Market in Japan of Americas, APAC, EMEA region.
For Any Query, Contact Our Expert @ http://www.marketreportsworld.com/enquiry/pre-order-enquiry/10280146
Further, the Regenerative Medicine Market in Japan report states that currently, the regenerative medicine market in Japan is lagging behind the other developed nations such as the US and few European countries such as Germany and the UK. The Japanese market has witnessed only four product approvals in 2014, which constitute a serious challenge to compete with other Western markets. On the other hand, by 2012 itself, the governments in Europe have approved 20 regenerative medicines, followed by South Korea with 14, and the US with nine. The low rate of product approval is due to the old regulatory system in Japan. Further, the less technological expertise of local vendors for the development of innovative regenerative medicine is another reason for a low competitive edge.
Key questions answered in Regenerative Medicine Market in Japan report:
- What will the Regenerative Medicine Market in Japan size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving Regenerative Medicine market?
- What are the challenges to Regenerative Medicine market growth?
- Who are the key vendors in Regenerative Medicine market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
No of Pages: 102
Price of Report: $ 2500 (Single User License)
Purchase Report @ http://www.marketreportsworld.com/purchase/10280146
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1 408 520 9750
Email – firstname.lastname@example.org